Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
Ebola virus (EBOV) can cause severe hemorrhagic fever in humans, and no approved treatment is currently available. Although several antibodies have achieved good protection in animal models, the potential emerging isolates of ebolavirus and the unknown effects of experimental antibodies in humans un...
Saved in:
Main Authors: | Pengfei Fan (Author), Xiangyang Chi (Author), Guodong Liu (Author), Guanying Zhang (Author), Zhengshan Chen (Author), Yujiao Liu (Author), Ting Fang (Author), Jianmin Li (Author), Logan Banadyga (Author), Shihua He (Author), Changming Yu (Author), Xiangguo Qiu (Author), Wei Chen (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo
by: Logan Banadyga, et al.
Published: (2019) -
Closer than ever to an Ebola virus vaccine
by: Logan Banadyga, et al.
Published: (2017) -
Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.
by: Xiangguo Qiu, et al.
Published: (2012) -
Monoclonal antibodies as potent therapeutics in dentistry.
by: Pratichi Tripathi, et al.
Published: (2019) -
Production and Characterization of a Monoclonal Antibody Neutralizing Poliovirus Type 2
by: Morteza Kamalzadeh, et al.
Published: (2019)